GVHD: In vivo veritas

Blood

Volumn 106, Issue 3, 2005, Pages 772-773

  Ferrara, James L M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; HISTOLOGY; IMMUNOFLUORESCENCE MICROSCOPY; LYMPHOCYTE HOMING; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; NOTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 23044499930     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2005-05-1925     Document Type: Note

References (5)

1. Antin JH, Deeg HJ. Clinical spectrum of acute graft-vs.-host disease. In: Ferrara JLM, Deeg HJ, Burakoff SJ, eds. Graft-vs-Host Disease. 3rd ed. New York, NY: Marcel Dekker; 2005:369-382.
2. Cooke KR, Yanik G. Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease? Bone Marrow Transplant. 2004;34:753-765.
3. Hill G, Ferrara J. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood. 2000;95:2754-2759.
4. Murai M, Yoneyama H, Ezaki T, et al. Fever's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol. 2003;4:154-160.
5. Mackall CL, Hakim FT, Velardi A. The immune system in graft-vs.host disease: target and effector organ. In: Ferrara JLM, Deeg HJ, Burakoff SJ, eds. Graft-vs-Host Disease. 3rd ed. New York, NY: Marcel Dekker; 2005:195-228.